PMID- 32335278 OWN - NLM STAT- MEDLINE DCOM- 20210419 LR - 20210419 IS - 1872-7913 (Electronic) IS - 0924-8579 (Linking) VI - 56 IP - 1 DP - 2020 Jul TI - Synergistic phage-surfactant combination clears IgE-promoted Staphylococcus aureus aggregation in vitro and enhances the effect in vivo. PG - 105997 LID - S0924-8579(20)30155-2 [pii] LID - 10.1016/j.ijantimicag.2020.105997 [doi] AB - Currently, topical antibiotic treatment is a major strategy for decolonisation of Staphylococcus aureus, although it may result in antibiotic resistance or recolonisation of the organism. Recently, application of bacteriophages in the treatment of S. aureus infection has attracted attention. However, a single administration of bacteriophages did not effectively decolonise S. aureus in our first trial in vivo. Using a bacteriophage (pSa-3) and surfactant combination in vitro, we showed an increased (>8%) adsorption rate of the bacteriophage on the host. Moreover, the combination increased the eradication of immunoglobulin E (IgE)-stimulated aggregation, as the surfactant promoted the dissociation of S. aureus aggregates by decreasing the size by 75% and 50% in the absence and presence of IgE, respectively. Furthermore, the combined treatment significantly decolonised the pathogen with an efficacy double that of the phage-only treatment, and decreased the expression of pro-inflammatory cytokine genes (IL-1beta, IL-12 and IFNgamma) for 5 days in the second in vivo trial. These results suggest that the bacteriophage-surfactant combination could act as an alternative to antibiotics for S. aureus decolonisation in patients with dermatitis. CI - Copyright (c) 2020 Elsevier Ltd. All rights reserved. FAU - Kim, Sang Guen AU - Kim SG AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Giri, Sib Sankar AU - Giri SS AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Yun, Saekil AU - Yun S AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Kim, Hyoun Joong AU - Kim HJ AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Kim, Sang Wha AU - Kim SW AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Kang, Jeong Woo AU - Kang JW AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Han, Se Jin AU - Han SJ AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Kwon, Jun AU - Kwon J AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Oh, Woo Taek AU - Oh WT AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. FAU - Jun, Jin Woo AU - Jun JW AD - Department of Aquaculture, Korea National College of Agriculture and Fisheries, Jeonju-si, Republic of Korea. FAU - Park, Se Chang AU - Park SC AD - Laboratory of Aquatic Biomedicine, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, Republic of Korea. Electronic address: parksec@snu.ac.kr. LA - eng PT - Journal Article DEP - 20200423 PL - Netherlands TA - Int J Antimicrob Agents JT - International journal of antimicrobial agents JID - 9111860 RN - 0 (Interleukin-1beta) RN - 0 (Surface-Active Agents) RN - 187348-17-0 (Interleukin-12) RN - 37341-29-0 (Immunoglobulin E) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - Bacterial Adhesion/*drug effects MH - Bacteriophages/*metabolism MH - Dermatitis, Atopic/*drug therapy/microbiology MH - Humans MH - Immunoglobulin E/immunology MH - Interferon-gamma/biosynthesis MH - Interleukin-12/biosynthesis MH - Interleukin-1beta/biosynthesis MH - Mice MH - Mice, Inbred BALB C MH - Phage Therapy/*methods MH - Staphylococcal Skin Infections/*drug therapy MH - Staphylococcus aureus/drug effects/immunology/virology MH - Surface-Active Agents/*pharmacology OTO - NOTNLM OT - Aggregation OT - Bacteriophage OT - Staphylococcus aureus OT - Surfactant OT - Synergy OT - Topical treatment EDAT- 2020/04/27 06:00 MHDA- 2021/04/20 06:00 CRDT- 2020/04/27 06:00 PHST- 2019/10/15 00:00 [received] PHST- 2020/04/15 00:00 [revised] PHST- 2020/04/17 00:00 [accepted] PHST- 2020/04/27 06:00 [pubmed] PHST- 2021/04/20 06:00 [medline] PHST- 2020/04/27 06:00 [entrez] AID - S0924-8579(20)30155-2 [pii] AID - 10.1016/j.ijantimicag.2020.105997 [doi] PST - ppublish SO - Int J Antimicrob Agents. 2020 Jul;56(1):105997. doi: 10.1016/j.ijantimicag.2020.105997. Epub 2020 Apr 23.